Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) engineered for enhanced stability and receptor interaction in controlled laboratory environments. It has been widely studied for its ability to stimulate endogenous growth hormone (GH) release through activation of pituitary GHRH receptors.